The 5-gene signature (AHCY, NCAN, FBP2, GALNT3, and AKR1C2) in the model showed good clinical prediction potency in TS, IVS and EVS, and the transcriptional profile was validated by the use of NB samples from our own hospital. Here, AKR1C2 is linked to neuroblastoma.